- 3501. DRUG PERSISTING DEMENTIA
- [ ] (UMLS (ICD9CM) C1456288) Drug-induced persisting dementia;
=Mental or Behavioral Dysfunction | - 3551. DRUGS, MEDICINAL AND BIOLOGICAL SUBSTANCES CAUSING ADVERSE EFFECTS IN THERAPEUTIC USE
- [ ] (UMLS (ICD9CM) C0178359) =Injury or Poisoning
|
- 3502. drug preservation
- [preventing drugs or pharmaceuticals from decay, separation, being rendered useless, or extending the shelf life of drugs by means of a chemical agent, cooling, or other physical process. ( CSP )] (UMLS (CSP) C0728909) =Laboratory Procedure =preservation;
| - 3552. DRUSEN (DEGENERATIVE)
- [Colloid or hyaline bodies lying beneath the retinal pigment epithelium. They may occur either secondary to changes in the choroid that affect the pigment epithelium or as an autosomal dominant disorder of the retinal pigment epithelium. ( MSH )] (UMLS (ICD9CM) C0035312) =Disease or Syndrome ;
=Degeneration of retina;
|
- 3503. Drug Preservative
- [Chemicals that are added to drug products to prolong shelf life and maintain sterility. Protection of formulations, especially aqueous solutions, against microbial growth requires use of either antibacterial or antifungal preservatives. Generally, such agents are active against either bacteria or fungi but a few are active against both. The antimicrobials include but not limited to chlorobutanol, benzyl alcohol, sodium benzoate, sorbic acid, and phenol. The antioxidizing agents include butylated hydroxytolune, hydroxyanisole, propyl gallate, and sulfites. The necessary addition of preservatives for both safety and economy sometimes has been associated with significant adverse effects in certain patient populations. ( NCI )] (UMLS (NCI) C0033086) =Biomedical or Dental Material ;
=inactive ingredient;
| - 3553. DRUSEN OF OPTIC DISC
- [Optic disk bodies composed primarily of acid mucopolysaccharides that may produce pseudopapilledema (elevation of the optic disk without associated INTRACRANIAL HYPERTENSION) and visual field deficits. Drusen may also occur in the retina (see RETINAL DRUSEN). (Miller et al., Clinical Neuro-Ophthalmology, 4th ed, p355) ( MSH )] (UMLS (ICD9CM) C0029128) =Disease or Syndrome ;
=Optic Nerve Diseases;
|
- 3504. drug production
- [ ] (UMLS (CSP) C0920698) =Biomedical Occupation or Discipline
| - 3554. Dry
- (UMLS (HL7) C1550118) =Intellectual Product =Special Handling Code;
|
- 3505. DRUG PSY DIS W HALLUCIN
- [ ] (UMLS (ICD9CM) C1456732) Drug-induced psychotic disorder with hallucinations;
=Mental or Behavioral Dysfunction ;
| - 3555. dry
- [Keep in a dry environment ( HL7V3.0 )] (UMLS (HL7) C1550582) =Human-caused Phenomenon or Process =EntityHandling;
|
- 3506. DRUG PSYCH DISOR W DELUS
- [ ] (UMLS (ICD9CM) C1456286) Drug-induced psychotic disorder with delusions;
=Mental or Behavioral Dysfunction | - 3556. Dry Creek Rancheria of Pomo Indians of California
- (UMLS (HL7) C1554294) =Population Group =NativeEntityContiguous;
|
- 3507. drug quality
- [ ] (UMLS (CSP) C0920475) =Intellectual Product
| - 3557. dry eye
- [ ] (UMLS (CSP) C0314719) =Sign or Symptom ;
|
- 3508. drug quality/standard
- [levels of excellence which characterize drugs based on accepted standards of quality; standards of adequacy, acceptable performance, identification, quality and potency. ( CSP )] (UMLS (CSP) C0596464) =Intellectual Product =drug design/synthesis/production;
chemical standardization | - 3558. Dry Eye Syndrome
- [Corneal and conjunctival dryness due to deficient tear production, predominantly in menopausal and post-menopausal women. Filamentary keratitis or erosion of the conjunctival and corneal epithelium may be caused by these disorders. Sensation of the presence of a foreign body in the eye and burning of the eyes may occur. ( MSH )] (UMLS (NCI) C0013238) =Disease or Syndrome =Disorders of lacrimal system;
=KCS;
CONJUNCTIVAL XEROSIS;
Sjogren's syndrome;
|
- 3509. Drug reactions and intoxications specific to newborn
- [ ] (UMLS (ICD9CM) C0270275) =Injury or Poisoning
| - 3559. Dry Ice
- [A solid form of carbon dioxide used as a refrigerant. At temperatures above -78.5 degrees C and ambient pressure, it changes directly to a gas as it absorbs heat. ( NCI )] (UMLS (NCI) C0013239) =Inorganic Chemical
|
- 3510. drug receptor
- [proteins that bind specific drugs with high affinity and trigger intracellular changes influencing the behavior of cells; generally thought to be receptors for some endogenous substances not otherwise specified; postcoordinate with specific drug terms if needed. ( CSP )] (UMLS (CSP) C0034799) =Amino Acid, Peptide, or Protein; Receptor ;
=Receptor;
=opiate receptor;
cannabinoid receptor;
PCP receptor;
benzodiazepine receptor;
| - 3560. dry orgasm
- [Sexual climax without the release of semen from the penis. ( NCI )] (UMLS (NCI) C0403673) =Pathologic Function
|
- 3511. drug registry
- [ ] (UMLS (CSP) C0920476) =Intellectual Product
| - 3561. dry pint
- [1 [dqt_us]/2 ( HL7V3.0 )] (UMLS (HL7) C1552943) =Quantitative Concept =UnitOfMeasureAtomInsens;
UnitOfMeasureAtomSens |
- 3512. drug regulation
- [ ] (UMLS (CSP) C0013201) =Regulation or Law
| - 3562. dry quart
- [1 [pk_us]/8 ( HL7V3.0 )] (UMLS (HL7) C1552942) =Quantitative Concept =UnitOfMeasureAtomInsens;
UnitOfMeasureAtomSens |
- 3513. Drug Rehab
- [Provision of treatment for drug abuse. ( HL7V3.0 )] (UMLS (HL7) C1555458) =Intellectual Product =ActMedicalServiceCode;
| - 3563. Ds
- [Supernumerary maxillary right lateral primary incisor ( HL7V3.0 )] (UMLS (HL7) C1552149) =Body Part, Organ, or Organ Component =SUPERNUMERARY TEETH;
|
- 3514. DRUG REHAB/DETOX
- (UMLS (ICD9CM) C0204602) =Therapeutic or Preventive Procedure
| - 3564. DS-4152
- (UMLS (NCI) C0212199) =Carbohydrate; Pharmacologic Substance
|
- 3515. DRUG REHABILITATION
- [ ] (UMLS (ICD9CM) C0204601) =Therapeutic or Preventive Procedure
| - 3565. DSM
- [ ] (UMLS (CSP) C0599833) =Intellectual Product ;
|
- 3516. drug related cancer
- [ ] (UMLS (CSP) C0920477) =Neoplastic Process
| - 3566. DSR
- [ ] (UMLS (CSP) C0596468) =Diagnostic Procedure
|
- 3517. drug related diabetes mellitus
- [diabetes mellitus caused by medicinal substances given to or taken by the patient; concept excludes diabetes resulting from exposure to nonmedicinal chemicals in the environment or drugs of abuse, for which see TOXICOLOGY. ( CSP )] (UMLS (CSP) C0271646) =Disease or Syndrome =Diabete mellito;
drug adverse effect | - 3567. DSR/ACK - Deferred response to a query
- (UMLS (HL7) C1549307) =Health Care Activity =Event Type;
|
- 3518. drug related neoplasm
- [ ] (UMLS (CSP) C0920478) =Neoplastic Process
| - 3568. dT
- [pyrimidine nucleoside, thymine linked by its N1 nitrogen to C1 carbon of ribose. ( CSP )] (UMLS (NCI) C0040077) =Nucleic Acid, Nucleoside, or Nucleotide; Biologically Active Substance ;
=deoxyribonucleoside;
pyrimidine nucleoside =3'-Azido-3'-deoxythymidine;
2'-Deoxy-5-trifluoromethyluridine;
3'-Azido-3'-deoxythymidine;
1-(2,3-Dideoxy-beta-glycero-pent-2-enofuranosyl)thymine |
- 3519. drug related neoplasm/cancer
- [neoplasm or cancer caused or exacerbated by medicinal substances given to or taken by the patient; concept excludes neoplasms or cancer resulting from exposure to nonmedicinal chemicals in the environment or drugs of abuse, for which see TOXICOLOGY or CHEMICAL RELATED NEOPLASM/CANCER. ( CSP )] (UMLS (CSP) C0872034) =Neoplastic Process ;
=drug adverse effect;
chemical related neoplasm/cancer | - 3569. DT (pediatric)
- [diphtheria and tetanus toxoids, adsorbed for pediatric use ( HL7V3.0 )] (UMLS (HL7) C0694727) =Pharmacologic Substance; Immunologic Factor =Vaccines administered (code = CVX)(parenteral, unless oral is noted);
VaccineType |
- 3520. drug resistance
- [tendency of biological systems (organisms, cells, or cell-free systems) to fail to respond as expected to drug treatment or exposure; may be due to specific enzymes, transporters, or receptors which block drug action. ( CSP )] (UMLS (CSP) C0013203) =Biologic Function =Pharmacologic;
=MDR;
pesticide resistance;
insulin sensitivity/resistance;
| - 3570. DTaP
- [diphtheria, tetanus toxoids and acellular pertussis vaccine ( HL7V3.0 )] (UMLS (HL7) C0694728) =Pharmacologic Substance; Immunologic Factor =Vaccines administered (code = CVX)(parenteral, unless oral is noted);
VaccineType |
- 3521. Drug Resistance Inhibition Treatment
- [Treatment used to make cancer cells less resistant to anticancer drugs. ( NCI )] (UMLS (NCI) C0677911) =Therapeutic or Preventive Procedure ;
| - 3571. DTaP, 5 pertussis antigens
- (UMLS (HL7) C1548471) =Pharmacologic Substance; Immunologic Factor ;
=Vaccines administered (code = CVX)(parenteral, unless oral is noted);
|
- 3522. drug resource
- [ ] (UMLS (CSP) C0920699) =Intellectual Product
| - 3572. DTaPHib
- [DTaP-Haemophilus influenzae type b conjugate vaccine ( HL7V3.0 )] (UMLS (HL7) C0694729) =Pharmacologic Substance; Immunologic Factor =Vaccines administered (code = CVX)(parenteral, unless oral is noted);
VaccineType |
- 3523. drug screening
- [Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. ( MSH )] (UMLS (CSP) C0013206) =Research Activity
| - 3573. DTC 101
- (UMLS (NCI) C1328677) =Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance
|
- 3524. Drug Screening
- (UMLS (HL7) C1548848) =Health Care Activity =Consent Type;
| - 3574. DTI-015
- (UMLS (NCI) C1328663) =Organic Chemical; Pharmacologic Substance
|
- 3525. drug screening/evaluation
- [testing and evaluation of the safety, efficacy, and dosage parameters of drugs; do not confuse with DRUG DETECTION. ( CSP )] (UMLS (CSP) C0178605) =Research Activity =drug design/synthesis/production;
evaluation/testing =Placebo | - 3575. DTIC-Dome
- (UMLS (NCI) C0699717) =Organic Chemical; Pharmacologic Substance ;
|
- 3526. drug seeking behavior
- [ ] (UMLS (CSP) C0694536) =Individual Behavior
| - 3576. dTMP kinase
- [ ] (UMLS (CSP) C0058778) =Amino Acid, Peptide, or Protein; Enzyme =other phosphotransferase;
|
- 3527. drug sensitivity
- [ ] (UMLS (CSP) C0237865) =Organism Attribute
| - 3577. dTMP Synthase
- [Human thymidylate synthetase protein (312 aa, 36 kDa) is encoded by the human (TYMS) gene. The protein is a conserved transferase enzyme that catalyzes methylene tetrahydrofolate (MTHF)/dUMP conversion to dihydrofolate/dTMP in thymidine triphosphate/deoxyribonucleotide biosynthesis. Thymidylate synthetase competes with the methylene tetrahydrofolate receptor for MTHF and maintains the dTMP pool for DNA replication and repair. ( NCI )] (UMLS (NCI) C0040085) =Amino Acid, Peptide, or Protein; Enzyme ;
=EC 2.1.1;
|
- 3528. Drug Sensitization
- [The term describes the situation in which a constant drug dose elicits increasing effects.The condition is opposite to drug tolerance since less dose of the substance is required to reinstate the initial effect (reverse-tolerance). The concept does not refer to cumulative drug effect. ( NCI )] (UMLS (NCI) C0475453) =Therapeutic or Preventive Procedure ;
| - 3578. DTP
- [diphtheria, tetanus toxoids and pertussis vaccine ( HL7V3.0 )] (UMLS (HL7) C0012559) =Organic Chemical; Pharmacologic Substance; Immunologic Factor =Vaccines administered (code = CVX)(parenteral, unless oral is noted);
VaccineType |
- 3529. drug standard
- [ ] (UMLS (CSP) C0920479) =Intellectual Product
| - 3579. DTP-DPP
- [A lipophilic disaccharide derivative of muramyl dipeptide (MDP) with strong immunostimulating activity and used as a vaccine adjuvant. MDP, a component of bacterial cell wall, is the minimum chemical structure required for macrophage activation. Due to MDP's toxicity and short duration of action, theramide was developed with improved stability, and can be administered without a liposome carrier. Theramide stimulates macrophage activity, which in turn potentiates other immune responses, including the release of proinflammatory interleukins and tumor necrosis factor alpha (TNF alpha). The release of these cytokines further augments the activation of cellular and humoral immune system. ( NCI )] (UMLS (NCI) C0281665) =Organic Chemical; Pharmacologic Substance
|
- 3530. drug storage
- [ ] (UMLS (CSP) C0013211) =Therapeutic or Preventive Procedure
| - 3580. DTP-Hib
- [DTP-Haemophilus influenzae type b conjugate vaccine ( HL7V3.0 )] (UMLS (HL7) C0694730) =Pharmacologic Substance; Immunologic Factor =Vaccines administered (code = CVX)(parenteral, unless oral is noted);
VaccineType |
- 3531. drug structure
- [ ] (UMLS (CSP) C1328874) =Intellectual Product; ;
| - 3581. DTP-Hib-Hep B
- (UMLS (HL7) C1548467) =Pharmacologic Substance; Immunologic Factor ;
=Vaccines administered (code = CVX)(parenteral, unless oral is noted);
|
- 3532. drug structure function
- [ ] (UMLS (CSP) C1328875) =Qualitative Concept; ;
| - 3582. DTPA/IFN-A/MOAB CC49
- (UMLS (NCI) C0338351) =Therapeutic or Preventive Procedure ;
|
- 3533. Drug Suspending Agent
- [Therapeutically inactive ingredient of pharmaceutical dosage form used to prevent aggregation of the active drug in liquid form, allowing uniform concentrations to be maintained for accurate dosing. ( NCI )] (UMLS (NCI) C0038959) =Biomedical or Dental Material
| - 3583. Dual
- [Dual purpose. Defined purposes based on species and breed ( HL7V3.0 )] (UMLS (HL7) C1554184) =Intellectual Product =LivingSubjectProductionClass;
|
- 3534. drug synthesis
- [ ] (UMLS (CSP) C0920480) Drug Synthesis and Chemistry =Biomedical Occupation or Discipline
| - 3584. dual personality
- [ ] (UMLS (CSP) C0013259) =Mental or Behavioral Dysfunction
|
- 3535. drug test (pharmacology)
- [ ] (UMLS (CSP) C0598332) =Laboratory Procedure
| - 3585. dual photon absorptiometry
- [ ] (UMLS (CSP) C0013260) =Diagnostic Procedure
|
- 3536. drug tolerance
- [tendency of a drug, with repeated use, to become less effective (i.e., require higher dosage) or associated with user dependence; do not use for lack of adverse reactions, as in "the subject tolerated the drug well". ( CSP )] (UMLS (CSP) C0013220) =Finding =Pharmacologic;
=insulin sensitivity/resistance;
| - 3586. Dual Purpose
- (UMLS (HL7) C1547278) =Intellectual Product =Production Class Code;
|
- 3537. Drug Toxicity
- [An adverse effect of a drug used therapeutically or diagnostically. ( NCI )] (UMLS (NCI) C0013221) =Injury or Poisoning =poisoning;
=dermatitis medicamentosa;
Serotonin Syndrome;
Tricyclic Antidepressant Toxicity;
Quinidine Toxicity;
Qinine Toxicity;
Aminoquinolone Toxicity | - 3587. DUAL SENSORY IMPAIRMENT
- [ ] (UMLS (ICD9CM) C1955602) =Disease or Syndrome
|
- 3538. Drug Transport
- [Any subcellular or molecular event, process, or condition involved in translocation of a drug from one site or compartment to another. (NCI) ( NCI )] (UMLS (NCI) C1154689) =Cell Function
| - 3588. Dual Specificity Phosphatase 1
- [Dual Specificity Phosphatase 1, encoded by the DUSP1 gene, is induced by oxidative stress and heat shock. This protein specifically inactivates mitogen-activated protein (MAP) kinase in vitro by the concomitant dephosphorylation of both its phosphothreonine and phosphotyrosine residues. Furthermore, it suppresses the activation of MAP kinase by oncogenic ras in extracts of Xenopus oocytes. DUSP1 may play an important role in the human cellular response to environmental stress as well as in the negative regulation of cellular proliferation. (from LocusLink and Swiss-Prot) ( NCI )] (UMLS (NCI) C0287531) =Amino Acid, Peptide, or Protein; Enzyme ;
|
- 3539. Drug Vehicle
- [carrier or inert medium used as a solvent (or diluent) in which the medicinally active agent is formulated and or administered. ( CSP )] (UMLS (NCI) C0042444) =Biomedical or Dental Material =DDS;
| - 3589. Dual Specificity Phosphatase 22 Gene
- [This gene is involved in the inactivation of proteins which participate in cellular differentiation and proliferation. ( NCI )] (UMLS (NCI) C1423960) DUSP22;
DUSP22 Gene =Gene or Genome |
- 3540. Drug withdrawal
- (UMLS (HL7) C1546942) =Idea or Concept =Event Qualification;
| - 3590. Dual Specificity Phosphatase 3
- [Encoded by human DUSP3 Gene, 185-amino acid 20.5 kD conserved VH1-Related Phosphatase is a non-receptor member of the dual specificity protein phosphatase subfamily (Protein-Tyrosine Phosphatase Family) that inactivates target substrates by dephosphorylating phosphotyrosine and phosphoserine/threonine residues. Negative regulators of MAPK/ERK, SAPK/JNK, and p38 members associated with cellular proliferation and differentiation, dual specificity phosphatases show different tissue distributions and subcellular locations, distinct substrate specificities for MAP kinases, and different modes of induction by extracellular stimuli. (from Swiss-Prot, OMIM, and NCI) ( NCI )] (UMLS (NCI) C1333317) Dual Specificity Protein Phosphatase 3;
Dual Specificity Protein Phosphatase VHR;
DUSP3;
EC 3.1.3.16;
EC 3.1.3.48;
Serine/Threonine Specific Protein Phosphatase;
Vaccinia Virus Phosphatase VH1-Related;
VH1-Related Phosphatase;
=Amino Acid, Peptide, or Protein; Enzyme |
- 3541. DRUG WITHDRAWAL
- [physiological and psychological symptoms associated with withdrawal from the use of a drug after prolonged administration or habituation; the concept includes withdrawal from smoking or drinking, as well as withdrawal from an administered drug. ( CSP )] (UMLS (ICD9CM) C0152128) =Disease or Syndrome =Pharmacologic;
substance abuse related disorder | - 3591. Dual Specificity Phosphatase 3 (Vaccinia Virus Phosphatase VH1-Related) Gene
- [This gene plays a role in the inactivation of proteins involved in cellular differentiation and proliferation. ( NCI )] (UMLS (NCI) C1333258) DUSP3;
DUSP3 Gene;
=Gene or Genome ;
|
- 3542. Drug withdrawal syndrome in newborn
- [Fetal and neonatal addiction and withdrawal as a result of the mother's dependence on drugs during pregnancy. Withdrawal or abstinence symptoms develop shortly after birth. Symptoms exhibited are loud, high-pitched crying, sweating, yawning and gastrointestinal disturbances. ( MSH )] (UMLS (ICD9CM) C0027609) =Disease or Syndrome =Infant, Newborn, Diseases;
Substance-Related Disorders | - 3592. Dual Specificity Protein Kinase TTK
- [Expressed as a 4-kb mRNA in proliferating cells by human TTK Gene (Ser/Thr Kinase Family), 841-aa 95-kDa TTK Protein Kinase is a likely dual-specificity kinase since it phosphorylates proteins on tyrosine as well as serine and threonine. TTK is probably associated with kinetochore or centrosome function in cell proliferation. Kinetochore-associated Mps1 kinase (Xenopus) is necessary to establish and maintain the mitotic checkpoint. Required for kinetochore recruitment and retention of active CENPE, Mps1 is necessary for Mad1 and Mad2 kinetochore association and inhibition of the Anaphase-Promoting Complex/Cyclosome. Mps1 (mouse), a Cdk2 substrate, regulates centrosome duplication jointly with Cdk2. By regulating Mps1 S phase stability, Cdk2 promotes centrosome duplication by Mps1. (NCI) ( NCI )] (UMLS (NCI) C1336689) ESK;
ESK Homologue;
Monopolar Spindle 1-Like 1;
MPS1L1;
Phosphotyrosine-Picked Threonine Kinase;
PYT;
TTK;
TTK Protein Kinase =Amino Acid, Peptide, or Protein; Enzyme |
- 3543. Drug-Induced Aplastic Anemia
- (UMLS (NCI) C0271909) =Disease or Syndrome
| - 3593. Dual-Specificity Phosphoprotein Phosphatase
- [Dual-specificity protein phosphatases are a subclass of protein tyrosine phosphatases that are uniquely able to hydrolyse the phosphate ester bond on both a tyrosine and a threonine or serine residue on the same protein. Dual-specificity phosphatases have a central role in the complex regulation of signalling pathways that are involved in cell stress responses, proliferation and death. (from Nat Rev Drug Discov 2002;1:961-76) ( NCI )] (UMLS (NCI) C1333316) =Amino Acid, Peptide, or Protein; Enzyme
|
- 3544. DRUG-INDUCED DELIRIUM
- [ ] (UMLS (ICD9CM) C0154326) =Disease or Syndrome
| - 3594. Dubin Johnson syndrome
- [A benign, autosomally recessive inherited hyperbilirubinemia characterized by the presence of a dark pigment in the centrilobular region of the liver cells. There is a functional defect in biliary excretion of bilirubin, cholephilic dyes, and porphyrins. Affected persons may be asymptomatic or have vague constitutional or gastrointestinal symptoms. The liver may be slightly enlarged, and oral and intravenous cholangiography fails to visualize the biliary tract. ( MSH )] (UMLS (CSP) C0022350) =Disease or Syndrome ;
=Jaundice, Neonatal;
Congenital Metabolic Disorder |
- 3545. DRUG-INDUCED MOOD DISORD
- [ ] (UMLS (ICD9CM) C0338715) =Mental or Behavioral Dysfunction
| - 3595. Duchenne muscular dystrophy
- [X-linked recessive muscle disease caused by an inability to synthesize dystrophin, which is involved with maintaining the integrity of the sarcolemma; muscle fibers undergo a process that features degeneration and regeneration; clinical manifestations include proximal weakness in the first few years of life, pseudohypertrophy, cardiomyopathy and an increased incidence of impaired mentation; Becker muscular dystrophy is a closely related condition featuring a later onset of disease (usually adolescence) and a slowly progressive course. ( CSP )] (UMLS (CSP) C0013264) =Disease or Syndrome =HERED PROG MUSC DYSTRPHY;
|
- 3546. Drug-Induced Psychosis
- (UMLS (NCI) C0033937) =Mental or Behavioral Dysfunction
| - 3596. duck
- [any of various swimming birds (family Anatidae, the duck family) in which the neck and legs are short, the body more or less depressed, the bill often broad and flat, and the sexes almost always different from each other in plumage. ( CSP )] (UMLS (CSP) C0013268) =Bird =Aves;
|
- 3547. drug/alcohol abstinence
- [refraining from the use of alcohol or drugs of abuse. ( CSP )] (UMLS (CSP) C0872032) =Individual Behavior ;
=substance abuse related behavior;
| - 3597. duck hepatitis B virus
- [DNA virus that closely resembles human hepatitis B virus; it has been recovered from naturally infected ducks; do not confuse with Duck Hepatitis Virus 1 or 2, which is a picornavirus. ( CSP )] (UMLS (CSP) C0019171) =Virus ;
=Hepadnaviridae;
|
- 3548. DrugActionDetectedIssueCode
- [Proposed therapy may be contraindicated or ineffective based on an existing or recent drug therapy ( HL7V3.0 )] (UMLS (HL7) C1699639) =Intellectual Product ;
=AdministrationDetectedIssueCode;
| - 3598. duck hepatitis virus 1
- [ ] (UMLS (CSP) C0949286) =Virus
|
- 3549. DrugEntity
- [A substance whose therapeutic effect is produced by chemical action within the body. ( HL7V3.0 )] (UMLS (HL7) C1699392) =Intellectual Product =MaterialEntityClassType;
=ClinicalDrug | - 3599. duck hepatitis virus 2
- [ ] (UMLS (CSP) C0969632) =Virus
|
- 3550. Drugs primarily affecting the autonomic nervous system causing adverse effects in therapeutic use
- [ ] (UMLS (ICD9CM) C0543418) =Injury or Poisoning
| - 3600. Duckwater Shoshone Tribe of the Duckwater Reservat
- (UMLS (HL7) C1554295) =Population Group =NativeEntityContiguous;
|
home
